Structures by: Yu Y. M.
Total: 16
C15H12ClNO2
C15H12ClNO2
Organic letters (2017) 19, 5 1224-1227
a=8.710(6)Å b=16.465(9)Å c=9.372(5)Å
α=90° β=103.207(14)° γ=90°
C40H39N3O2
C40H39N3O2
Organic letters (2017) 19, 5 1224-1227
a=14.658(6)Å b=7.843(3)Å c=14.692(6)Å
α=90.00° β=109.942(8)° γ=90.00°
(Y0.60 Yb0.136 Er0.015 Ce0.03 Ca0.219) (Ca0.89 Y0.075 Yb0.032 Er0.003)2 Ca2 O (B O3)3
B3Ca3.999Ce0.03Er0.021O10Y0.75Yb0.2
Neorganicheskie Materialy (2001) 37, 1235-1245
a=8.063Å b=15.995Å c=3.5231Å
α=90° β=101.15° γ=90°
(Y0.584 Yb0.17 Er0.015 Ca0.231) (Ca0.884 Y0.073 Yb0.04 Er0.003)2 Ca2 O (B O3)3
B3Ca3.999Er0.021O10Y0.73Yb0.25
Neorganicheskie Materialy (2001) 37, 1235-1245
a=8.065Å b=15.998Å c=3.5243Å
α=90° β=101.17° γ=90°
(Y0.792 Ca0.208) (Ca0.938 Y0.062)2 Ca2 O0.96 (B O3)3
B3Ca4.084O9.96Y0.916
Neorganicheskie Materialy (2001) 37, 1235-1245
a=8.069Å b=16.005Å c=3.5275Å
α=90° β=101.17° γ=90°
(Y0.680 Yb0.102 Ca0.218) (Ca0.891 Y0.085 Yb0.024)2 Ca2 O (B O3)3
B3Ca4O10Y0.85Yb0.15
Neorganicheskie Materialy (2001) 37, 1235-1245
a=8.062Å b=15.996Å c=3.524Å
α=90° β=101.16° γ=90°
C12H18N0O7
C12H18N0O7
Journal of natural products (2009) 72, 5 921-924
a=5.481(1)Å b=9.784(1)Å c=24.207(1)Å
α=90.00° β=90.00° γ=90.00°
5-Fluorouracil Caffeic Acid
C4H3FN2O2?C9H8O4?2(H2O)
CrystEngComm (2020) 22, 45 7992-8006
a=6.9299(11)Å b=6.9584(10)Å c=15.946(2)Å
α=99.753(5)° β=96.384(5)° γ=98.812(5)°
Tegafur Syringic acid
C4H4.5F0.5NO1.5,C4.5H5O2.5
New Journal of Chemistry (2020) 44, 37 15994-16005
a=9.2818(13)Å b=6.7034(10)Å c=14.154(2)Å
α=90° β=95.260(4)° γ=90°
Indomethacin L-proline
C24H27ClN2O7
New Journal of Chemistry (2020) 44, 10 3930-3939
a=12.4240(5)Å b=5.7358(2)Å c=16.3820(6)Å
α=90° β=101.436(4)° γ=90°
C10H16CoN4O8S
C10H16CoN4O8S
Dalton transactions (Cambridge, England : 2003) (2013) 42, 28 10106-10111
a=23.5913(5)Å b=23.5913(5)Å c=13.7609(6)Å
α=90.00° β=90.00° γ=120.00°
C10H16MnN4O8S
C10H16MnN4O8S
Dalton transactions (Cambridge, England : 2003) (2013) 42, 28 10106-10111
a=23.8731(5)Å b=23.8731(5)Å c=13.8236(5)Å
α=90.00° β=90.00° γ=120.00°
7-Acetylamino-2,4-dimethyl-1,8-naphthyridine
C12H13N3O
Acta Crystallographica Section E (2008) 64, 1 o112-o112
a=7.970(8)Å b=7.309(7)Å c=19.071(18)Å
α=90.00° β=91.883(14)° γ=90.00°
Tris(2-ethyl-1<i>H</i>-imidazole-κ<i>N</i>^3^)(terephthalato-\ κ<i>O</i>)zinc(II)
C23H28N6O4Zn
Acta Crystallographica Section E (2009) 65, 5 m576
a=11.548(2)Å b=11.759(2)Å c=18.719(4)Å
α=90.00° β=91.79(3)° γ=90.00°
C18H38BF4NO6
C18H38BF4NO6
Journal of the American Chemical Society (2015) 137, 41 13345-13351
a=13.381(3)Å b=12.051(2)Å c=14.234(3)Å
α=90.00° β=90.00° γ=90.00°
C18H38ClNO10
C18H38ClNO10
Journal of the American Chemical Society (2015) 137, 41 13345-13351
a=13.2727(6)Å b=12.2599(6)Å c=14.2024(6)Å
α=90.00° β=90.00° γ=90.00°